Biotech Acquisition (OTCMKTS:BIOTU – Get Rating) rose 6.6% during trading on Tuesday . The company traded as high as $9.79 and last traded at $9.79. Approximately 102 shares were traded during trading, a decline of 99% from the average daily volume of 14,794 shares. The stock had previously closed at $9.18.
The business’s 50-day moving average price is $9.81 and its 200 day moving average price is $9.94.
A hedge fund recently raised its stake in Biotech Acquisition stock. Walleye Capital LLC raised its stake in shares of Biotech Acquisition (OTCMKTS:BIOTU – Get Rating) by 51.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 37,192 shares of the company’s stock after purchasing an additional 12,593 shares during the period. Walleye Capital LLC’s holdings in Biotech Acquisition were worth $369,000 as of its most recent SEC filing.
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Read More
- Get a free copy of the StockNews.com research report on Biotech Acquisition (BIOTU)
- It’s A Comfortable Time To Buy Steelcase
- Worthington Posts Strong Results, But Earnings Fall On One-Off Adjustments
- A Tasty Entry Point Into Darden Restaurants International
- NXP Semiconductors: Strong Earnings & New Microcontrollers for Electric Vehicles
- Lithium Stocks Are Offering Unprecedented Opportunity To Investors
Receive News & Ratings for Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
